Marcaine Spinal is a Subarachnoid Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Bupivacaine Hydrochloride.
| Product ID | 0409-1761_14f34fb6-d727-405e-b7ac-b73866265118 |
| NDC | 0409-1761 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Marcaine Spinal |
| Generic Name | Bupivacaine Hydrochloride In Dextrose |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBARACHNOID |
| Marketing Start Date | 2005-05-19 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018692 |
| Labeler Name | Hospira, Inc. |
| Substance Name | BUPIVACAINE HYDROCHLORIDE |
| Active Ingredient Strength | 8 mg/mL |
| Pharm Classes | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2005-06-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA018692 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2005-05-19 |
| Marketing Category | NDA |
| Application Number | NDA018692 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2005-06-16 |
| Marketing Category | NDA |
| Application Number | NDA018692 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-11-09 |
| Marketing Category | NDA |
| Application Number | NDA018692 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-11-09 |
| Ingredient | Strength |
|---|---|
| BUPIVACAINE HYDROCHLORIDE | 7.5 mg/mL |
| SPL SET ID: | 9679cc05-2f8a-4e88-53b5-6e9122c8b8c0 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0409-1761 | Marcaine Spinal | Bupivacaine Hydrochloride in Dextrose |
| 0409-3613 | Bupivacaine | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE |